MedTrace Logo

Pancreatectomy for NET: External Evaluation of WHO 2017 Grading System

NCT03791346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2019-04-18

No results posted yet for this study

Summary

Aim: The aim of this study was to investigate the clinicopathological factors and to evaluate the prognostic accuracy of the new World Health Organization (WHO) 2017 grading system in pancreatic neuroendocrine tumor (PanNET) patients.

Methods: Data collected between 1997 and December 2017 were analyzed. Histological grading and staging was based on the WHO 2017 grading system. Outcome after surgery and predictors of overall survival (OS) and disease free survival (DFS) were evaluated.

Conditions

  • Pancreatic Surgery

Sponsors & Collaborators

  • Department of digestive surgery, Carémeau Hospital, 30900, Nîmes, France

    collaborator UNKNOWN

  • Department of oncology, Carémeau Hospital, 30900, Nîmes, France

    collaborator UNKNOWN

  • Oncology - Institut du Cancer de Montpellier (ICM), Montpellier, France

    collaborator UNKNOWN

  • Digestive & Oncologic Surgery - Institut du Cancer de Montpellier (ICM), Montpellier, France

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • REGIS SOUCHE · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-01-01
Primary Completion
2017-12-01
Completion
2019-02-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03791346 on ClinicalTrials.gov